SCHEMBL3416704

SCHEMBL3416704

CC(C)Oc1ccc(C(=O)NCc2cc(-c3cccc(C(=O)O)c3)cc3c2OCC3)c(Cl)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 3/20 0.41
▸ PPARD Q03181 2/20 0.41
▸ PPARG P37231 2/20 0.41
▸ FABP4 P15090 2/20 0.41
▸ ACLY P53396 1/20 0.38
▸ NR1H4 Q96RI1 6/20 0.38
▸ EPHX2 P34913 2/20 0.38
▸ PTGES O14684 1/20 0.38
▸ RXRA P19793 1/20 0.37
▸ RXRB P28702 1/20 0.37
▸ WDR5 P61964 1/20 0.36
▸ MTNR1A P48039 1/20 0.35
▸ MTNR1B P49286 1/20 0.35
▸ LIFR P42702 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3417366 0.89 PPARD (0.45) PPARAPPARDPPARGFABP4ACLY
SCHEMBL13461068 0.88 PTGES (0.37) FABP4NR1H4EPHX2PTGESMTNR1A
SCHEMBL13433330 0.87 PPARA (0.46) PPARAPPARDPPARGFABP4ACLY
SCHEMBL3415535 0.82 PPARD (0.55) PPARAPPARDPPARGACLYNR1H4
SCHEMBL3417535 0.81 PPARA (0.45) PPARAPPARDPPARGFABP4ACLY
SCHEMBL3416748 0.81 PPARD (0.64) PPARAPPARDPPARGACLYEPHX2
SCHEMBL5549032 0.80 PTGES (0.37) PPARAPPARDPPARGNR1H4EPHX2
SCHEMBL3414385 0.79 PPARD (0.55) PPARAPPARDPPARGACLYEPHX2
SCHEMBL3416134 0.78 PPARD (0.59) PPARAPPARDPPARGNR1H4
SCHEMBL13460887 0.77 TP53 (0.37) PPARAPPARDPTGESMTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7687664-B2 Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-03-30 — — US disclosed
US-7687664-B2 Carboxylic acid derivative, a salt thereof or an ester of them, and medicament comprising it EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-03-30 — — US disclosed
US-20040214888-A1 Carboxylic acid derivative and medicine comprising salt or ester of the same EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-10-28 — — US disclosed
EP-1394147-A1 CARBOXYLIC ACID DERIVATIVE AND MEDICINE COMPRISING SALT OR ESTER OF THE SAME Eisai Co., Ltd. (JP) 2004-03-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040214888-A1 Carboxylic acid derivative and medicine comprising salt or ester of the same GPR119, NR3C1, INSR PPARA 130/4885PPARD 689/4885PPARG 238/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback